Cancer Immunology, Immunotherapy

, Volume 19, Issue 2, pp 109–114 | Cite as

Inhibition of growth and spontaneous metastasis of syngeneic transplantable tumors by an aromatic retinoic acid analogue

1. Relationship between tumour immunogenicity and responsiveness
  • Suzanne A. Eccles
  • Susan C. Barnett
  • Peter Alexander
Original Articles


Aromatic retinoic acid analogues selected for their favourable therapeutic ratios were tested for their effects on the growth (in vivo and in vitro) and spontaneous metastasis of a variety of murine sarcomas and carcinomas. Ro 10-1670 (a trimethylmethoxyphenyl analogue of retinoic acid) was used in in vitro studies, while its corresponding ethyl ester Ro 10-9359 was used for oral administration. Four of six fibrosarcomas, one of three squamous cell carcinomas, and one of five mammary adenocarcinomas responded to retinoid treatment in vivo by reduced growth rates (first detectable after 8–10 days), and in some cases by complete regression. The magnitude of the response was directly proportional to tumour immunogenicity, and eight tumours which failed to respond to retinoids did not evoke detectable transplantation immunity in syngeneic recipients. Retinoid administration did not significantly inhibit the development of spontaneous metastasis of non-immunogenic tumours, but decreased the incidence of secondary disease in the case of tumours of moderate immunogenicity. In vitro, retinoid treatments were generally without significant effects on tumour cell growth rate or morphology, and where growth inhibition was obtained it did not correlate with in vivo tumour responsiveness. No evidence of increased differentiation of retinoid-treated tumours was obtained either in vitro or in vivo. Taken together, the data suggest that in the 14 transplantable syngeneic tumours studied the inhibitory effects of retinoids on tumour growth and metastasis in vivo were mediated indirectly by potentiation of cell-mediated immunity directed against antigenic determinants on the tumour cell surface.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barnett SC, Eccles SA (1984) Studies of mammary carcinoma metastasis in a mouse model system. I: Derivation and characterisation of cells with different metastatic properties during tumour progression in vivo. Clin Exp Met 2:15–26Google Scholar
  2. 2.
    Bollag W (1975a) Prophylaxis of chemically induced epithelial tumors with an aromatic retinoic acid analog (Ro 10–9359). Eur J Cancer 11:721–724Google Scholar
  3. 3.
    Bollag W (1975b) Therapy of epithelial tumors with an aromatic retinoic acid analog. Chemotherapy 21:236–247Google Scholar
  4. 4.
    Bollag W, Hartmann HR (1983) Prevention and therapy of cancer with retinoids in animals and man. Cancer Survevs 2:293–314Google Scholar
  5. 5.
    Bollag W, Matter A (1981) From Vitamin A to retinoids in experimental and clinical oncology. Achievements, failures and outlook. Ann NY Acad Sci 359:9–23Google Scholar
  6. 6.
    Chauvenet PH, Paque RE (1982) Effect of all-trans-retinoic acid on induction lethality and immunogenicity of murine methylcholanthrene-induced fibrosarcomas. Int J Cancer 30:187–192Google Scholar
  7. 7.
    Chen TR (1977) In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res 104:255–262Google Scholar
  8. 8.
    Deneufbourg JM (1979) Anti-tumour effect of an aromatic retinoic acid analog in a mouse syngeneic transplantable sarcoma. Biomedicine 31:122–123Google Scholar
  9. 9.
    Eccles SA (1982a) Host factors in metastasis. In: Tumour progression and markers. Proceedings of VIth Meeting of EACR. Kugler, Amsterdam, pp 183–196Google Scholar
  10. 10.
    Eccles SA (1982b) Host immune mechanisms in the control of tumour metastasis In: Haskill S (ed) Tumour immunity in prognosis; the role of mononuclear cell infiltration. Dekker, New York, pp 37–74Google Scholar
  11. 11.
    Eccles SA (1983) Differentiation and neoplasia. Invasion and Metastasis: experimental systems. J Pathol 141:333–353Google Scholar
  12. 12.
    Eccles SA, Alexander P (1974) Macrophage content of tumours in relation to metastatic spread and host immune reaction. Nature 250:667–669Google Scholar
  13. 13.
    Felix EL, Loyd B, Cohen MH (1975) Inhibition of the growth and development of a transplantable murine melanoma by vitamin A. Science 189:886–888Google Scholar
  14. 14.
    Ito Y (1981) Effect of an aromatic retinoic acid analog (Ro 10–9359) on growth of virus-induced papilloma (Shope) and related neoplasia of rabbits. Eur J Cancer 17:35–42Google Scholar
  15. 15.
    Jetten AM, Jetten MER, Sherman MI (1979) Stimulation of differentiation of several murine embryonal carcinoma cell lines by retinoic acid. Exp Cell Res 124:381–391Google Scholar
  16. 16.
    Kurata R, Mickshe M (1977) Suppressed tumor growth and metastasis by Vitamin A+BCG in Lewis lung tumor-bearing mice. Oncology 34:212–215Google Scholar
  17. 17.
    Lotan R (1980) Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 605:33–91Google Scholar
  18. 18.
    Lotan R, Nicolson GL (1977) Inhibitory effects of retinoic acid or retinyl acetate on the growth of untransformed, transformed, and tumor cells in vitro. J Natl Cancer Inst 59:1717–1722Google Scholar
  19. 19.
    Mahrle G, Berger H (1982) DMBA-induced tumours and their prevention by aromatic retinoid (Ro 10–9359) Arch Dermatol Res 272:37–47Google Scholar
  20. 20.
    Malkovsky M, Medawar PB (1984) Retinoids and in vivo immunity to transplantable tumours: a terra relatively incognita. Immunology Today 5:178–180Google Scholar
  21. 21.
    Merriman RL, Bertram JS (1979) Reversible inhibition by retinoids of 3-methylcholanthrene-induced neoplastic transformation in C3H/10T 1/2 clone 8 cells. Cancer Res 39:1661–1666Google Scholar
  22. 22.
    Ong DE, Chytil F (1983) Vitamin A and cancer. Vitamins and Hormones. 40:105–144Google Scholar
  23. 23.
    Patek PQ, Collins JL, Yogeeswaran G, Dennert G (1979) Anti-tumour potential of retinoic acid: stimulation of immune-mediated effectors. Int J Cancer 24:624–628Google Scholar
  24. 24.
    Rettura G, Schittek A, Hardy M, Levenson SM, Demertriou A, Seifter E (1975) Antitumour action of Vitamin A in mice inoculated with adenocarcinoma cells. J Natl Cancer Inst 54:1489–1491Google Scholar
  25. 25.
    Rudland PS, Paterson FC, Davies AC, Warburton MJ (1983) Retinoid-specific induction of differentiation and reduction of the DNA synthesis rate and tumor-forming ability of a stem cell line from a rat mammary tumor. J Natl. Cancer Inst 70:949–958Google Scholar
  26. 26.
    Sporn MB, Roberts AB (1983) Role of retinoids in differentiation and carcinogenesis. Cancer Res 43:3034–3040Google Scholar
  27. 27.
    Trown PW, Buck MJ, Hansen R (1976) Inhibition of growth and regression of a transplantable rat chondrosarcoma by 3 retinoids. Cancer Treat Rep 60:1647–1653Google Scholar
  28. 28.
    Verma AK, et al. (1978) Inhibition of 12-O-tetradecanoyl phorbol-13-acetate induced ornithine decarboxylase activity in mouse epidermis by vitamin A analogs. Cancer Res 38:793–801Google Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • Suzanne A. Eccles
    • 1
  • Susan C. Barnett
    • 2
  • Peter Alexander
    • 3
  1. 1.Division of Tumour Immunology (Block X)Institute of Cancer ResearchBelmont, SuttonEngland
  2. 2.Tumour Biology Section, NCI, Public Health Service, NIHBethesdaUSA
  3. 3.Department of Medical OncologySouthampton General HospitalSouthamptonEngland

Personalised recommendations